Glaxo Settles Cases With US for $3 Billion
The British drug company GlaxoSmithKline said Thursday that it had agreed to pay $3 billion to settle United States government civil and criminal investigations into its sales practices for numerous drugs.
The settlement would be the largest yet in a wave of federal cases against pharmaceutical companies accused of illegal marketing, surpassing the previous record of $2.3 billion paid by Pfizer in 2009. In recent years, drug companies have been prime targets of federal fraud investigations, which have recovered tens of billions of dollars for Medicaid and Medicare.
The cases against GlaxoSmithKline include illegal marketing of Avandia, a diabetes drug that was severely restricted last year after it was linked to heart risks. Federal prosecutors said the company had paid doctors and manipulated medical research to promote the drug.
See the full, original post here: https://www.nytimes.com/2011/11/04/business/glaxo-to-pay-3-billion-in-avandia-settlement.html
About TriMark Legal Funding
TriMark was established in 2003 and is among the oldest legal funding companies in the nation. TriMark provides pre-settlement and post-settlement funding, sometimes called 'lawsuit settlement loans', to injured plaintiffs on hundreds of different types of personal injury lawsuits, employment lawsuits, workplace injury accidents and worker's comp lawsuits, mass torts, and multi-district litigation. We also provide attorney funding and law firm financing for plaintiffs' attorneys and law firms.
|Personal Injury Legal Funding||Multidistrict Litigation Financing|
Click here to see the original article.